Healthy aging is a multifactorial process influenced by genetic, environmental, and lifestyle factors. Unani medicine, rooted in Greco-Arabic traditions, presents a holistic framework for promoting longevity and preventing age-associated diseases. This review critically examines Unani principles relevant to healthy aging, elucidating the theoretical constructs, clinical applications, and scientific underpinnings. Evidence from recent studies and guideline-based recommendations are integrated to highlight the practical implications for clinicians and researchers in geriatric medicine.
Aging is an inevitable biological phenomenon associated with progressive physiological decline and increased vulnerability to chronic diseases. The global demographic shift toward an aging population necessitates innovative, culturally sensitive approaches to promote healthspan. Unani medicine, with its emphasis on temperament (Mizaj), humoral balance, and lifestyle (Ilaj-bil-Tadbeer), provides a distinctive perspective on healthy aging. This article explores the foundational Unani concepts, epidemiological context, mechanistic insights, and clinical strategies for healthy aging, with a focus on integrating traditional wisdom and contemporary research.
Globally, the proportion of individuals aged 60 years and above is rising, projected to reach 2.1 billion by 2050. Age-related diseases such as cardiovascular disorders, diabetes, neurodegenerative conditions, and musculoskeletal decline significantly affect quality of life and healthcare systems. In regions with substantial practice of Unani medicine (notably South Asia, the Middle East, and parts of Africa), traditional approaches remain integral to geriatric care. Epidemiological studies indicate that populations adhering to lifestyle modifications and dietary regimens rooted in Unani principles may exhibit lower prevalence of metabolic syndrome and age-related morbidity. However, systematic, large-scale research is warranted to delineate these associations more clearly.
Unani medicine posits that aging results from the gradual loss of innate heat (Hararat-e-Ghareeziya) and the imbalance of four humors: blood (Dam), phlegm (Balgham), yellow bile (Safra), and black bile (Sauda). Modern scientific interpretations align these concepts with inflammaging, oxidative stress, mitochondrial dysfunction, and hormonal changes. The Unani tenet that preservation of natural temperament and moderation of lifestyle factors can delay senescence finds resonance in current research on caloric restriction, antioxidant-rich diets, and stress reduction. Mechanistically, interventions targeting the reduction of chronic inflammation, improvement of metabolic flexibility, and maintenance of cellular homeostasis are central both to Unani and modern approaches to healthy aging.
Both Unani and contemporary medicine recognize genetic predisposition, environmental exposures, sedentary lifestyle, poor dietary habits, and psychosocial stress as key risk factors for accelerated aging. The Unani framework further categorizes risk factors based on individual temperament, seasonal variations, and balance of humors. For instance, individuals with a predominance of Balghami temperament (phlegmatic) are considered more susceptible to metabolic and degenerative disorders. This personalized risk stratification offers a nuanced approach to prevention and early intervention.
Clinically, aging manifests as frailty, cognitive decline, sarcopenia, sensory impairment, and increased susceptibility to infections. Unani physicians assess clinical features with a focus on temperament, pulse examination, and the presence of functional impairments. Early identification of subclinical changes such as mild forgetfulness, reduced stamina, or altered sleep patterns is pivotal for timely interventions. The Unani tradition also emphasizes the assessment of external signs (e.g., skin changes, hair graying) and internal symptoms (e.g., digestive disturbances), which often correlate with underlying pathophysiological processes.
Diagnosis in Unani medicine involves comprehensive clinical evaluation, including detailed history, temperament assessment, and physical examination. Tools such as the Mizaj (temperament) questionnaire, pulse analysis (Nabz), and urine examination (Baul) are utilized. While these methods differ from conventional diagnostics, they offer valuable insights for individualized care. Recent efforts to standardize and validate Unani diagnostic criteria using objective biomarkers and clinical outcomes are ongoing, aiming to bridge traditional and evidence-based medicine.
Management of healthy aging in Unani medicine encompasses pharmacological and non-pharmacological strategies. Ilaj-bil-Ghiza (dietotherapy) advocates for a balanced, temperament-specific diet rich in antioxidants, fibers, and essential nutrients. Ilaj-bil-Tadbeer (regimenal therapy) includes interventions such as exercise (Riyazat), massage (Dalk), cupping (Hijama), and hydrotherapy. Herbal medicines such as Asgandh (Withania somnifera), Amla (Emblica officinalis), and Saffron (Crocus sativus) are traditionally used for cognitive, musculoskeletal, and cardiovascular health. Integration with modern geriatric care involves careful consideration of drug-herb interactions, pharmacovigilance, and patient preferences.
Recent research has focused on bioactive compounds from Unani herbs demonstrating anti-inflammatory, neuroprotective, and anti-senescent properties. Preclinical and clinical studies have reported benefits of Unani formulations in cognitive enhancement, metabolic control, and reduction of frailty indices. Advances in systems biology and omics technologies are facilitating the identification of molecular targets and mechanisms of Unani interventions. Efforts are also underway to develop standardized, quality-assured herbal products and to conduct rigorous randomized controlled trials assessing efficacy and safety in elderly populations.
National and international geriatric guidelines increasingly recognize the relevance of integrative approaches. The AYUSH ministry in India, for example, has issued recommendations for incorporating Unani regimens in elderly care, emphasizing lifestyle modification, dietary guidance, and safe use of herbal medicines. Clinicians are encouraged to adopt a patient-centered, multidisciplinary approach, leveraging the strengths of Unani principles alongside conventional medicine to optimize outcomes. Emphasis is placed on individualized care plans, regular monitoring, and education to ensure adherence and prevent adverse events.
Unani principles provide a comprehensive, personalized framework for healthy aging, emphasizing the maintenance of humoral balance, temperament-based interventions, and holistic lifestyle management. While traditional practices are supported by emerging scientific evidence, further high-quality research is necessary to substantiate efficacy, safety, and mechanisms of action. Integration of Unani approaches with evidence-based geriatric medicine offers promising avenues for enhancing longevity and quality of life in the aging population, underscoring the importance of culturally competent, multidisciplinary care.
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa
3.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
4.
A new drug delivery system may help patients with a rare eye cancer
5.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
1.
Clonal Hematopoiesis and Healthy Aging: Clinical Implications, Mechanisms, and Emerging Perspectives
2.
Cemiplimab: A Revolutionary Drug For Treating Cancer
3.
Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections
4.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
5.
Unlocking the Benefits of Eltrombopag: A Comprehensive Guide
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation